Human Immunodeficiency Virus HIV Bulk Plasma Collected via Apheresis in ACDA

HIV Plasma is collected from IRB-consented donors diagnosed with HIV, using apheresis and ACDA (Acid-Citrate-Dextrose Formula A) as the anticoagulant. This disease-state plasma supports immunological and biomarker research and is ideal for assay development and therapeutic discovery.

Product Features

• High-volume plasma collected via apheresis
• Anticoagulated using ACDA
• Tested and confirmed negative for HBV and HCV
• Available fresh with custom volumes upon request
• IRB-approved informed consent and HIPAA-compliant handling

Donor Metadata

• Clinically confirmed diagnosis of HIV
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Clinical history and medication data available

Applications

• Disease-specific biomarker discovery
• Inflammatory and immunological assay development
• Proteomic, metabolomic, and cytokine profiling
• Therapeutic development and validation studies

Compliance and Quality Assurance

• Screened negative for HBV and HCV
• IRB-approved collection with 21 CFR Part 11–compliant consent
• Standardized processing and cryopreservation protocols

Ordering & Customization

HIV Bulk Plasma is available in standard or custom volumes. For documentation or international shipping, please contact [email protected].